Bacterial enzyme restores mitochondrial energy and slows aging in mammals

A research team has demonstrated that introducing a bacterial enzyme called lipoic acid protein ligase A (LplA) into mammalian mitochondria significantly improves cellular energy metabolism while managing oxidative damage—a longstanding challenge in longevity science. Lipoylation, the process by which this enzyme attaches lipoic acid to metabolic gatekeeper proteins, operates with greater efficiency in bacteria than in mammalian cells; when expressed in C. elegans and mouse models, it accelerates ATP synthesis while lowering reactive oxygen species (ROS) levels across the lifespan. Full-lifecycle studies show tangible benefits: enhanced motility and stress resistance in early life, and delayed age-related functional decline when intervention begins later. The primary barrier remains regulatory—skepticism about introducing bacterial proteins into humans due to potential immune responses—but the underlying finding is philosophically significant: this work suggests that energy enhancement and oxidative control need not be opposing forces, a premise that reshapes longevity medicine's central equation.